Document is current

Article History

Received: 29 April 2025

Accepted: 30 September 2025

First Online: 17 October 2025

Declarations

:

: Alice B. Gottlieb is an Editorial Board member of the American Journal of Clinical Dermatology. She was not involved in the selection of peer reviewers for this article nor in any editorial decisions regarding its disposition. Rahaf Zyad Attar and Sibel Aydinhave no conflicts of interest that are directly relevant to the content of this article. Alice B. Gottlieb has received research/educational grants from Bristol-Myers Squibb, Janssen, Moonlake, and UCB Pharma (all paid to Mount Sinai School of Medicine until 1 May, 2025). At UT Southwestern, she serves as a sub-investigator on studies sponsored by Janssen, Bristol-Myers Squibb, and UCB. She has also received honoraria as an advisory board member and consultant for Bristol-Myers Squibb, Eli Lilly, Janssen, Novartis, Oruka, Sanofi, SunPharma, Takeda, Teva, and UCB.

: This study was based on previously published literature and did not involve the collection of new human or animal data; therefore, ethical approval was not required.

: Not applicable.

: Not applicable.

: Not applicable. This article is based on previously published literature and does not include original data.

: Not applicable.

: RA performed the initial conceptualization, conducted the literature review, and wrote the manuscript. SA and ABG had supervised the conceptualization and contributed to the review and editing of the manuscript. All authors approved the final version.